Shai Erlich,James D. Thompson,Rabia Ozden,Elena Feinstein
申请号：
US15200544
公开号：
US20160304879A1
申请日:
2016.07.01
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present disclosure relates to methods of treating a patient suffering from or at risk of developing an ocular disease, disorder or injury, and includes treatment regimens using a double-stranded RNA compound that down-regulates CASP2 expression, or a pharmaceutically acceptable salt thereof.
